[Effect of clofibrate on serum lipids in atherosclerosis].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000008:administration & dosage; D001161:Arteriosclerosis / Q000188:drug therapy*; D002087:Butyrates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male
D000924:Anticholesteremic Agents; D000925:Anticoagulants; D002087:Butyrates; D008055:Lipids
Beeinflussung der Serumlipide durch Clofibrat bei der Atherosklerose.